compositions and methods for stimulating the efficacy of adoptive cellular immunotherapy

摘要

The present disclosure provides compositions and methods for stimulating, enhancing or enhancing the effectiveness of adoptive cellular immunotherapy using modified t-cells expressing an antigen binding protein in conjunction with modified cells (such as hematopoietic progenitor cells, immune system cells). modified human cells or a combination thereof) expressing the antigen specifically bound by the modified t-cell antigen binding protein.